Exploding head syndrome is one of the more alarming parasomnias in sleep medicine. Despite its dramatic name, it does not involve physical injury. Instead, people experience sudden loud noises, flashes of light, or shock like sensations when falling asleep or waking up. These episodes can cause intense fear, sleep paralysis, and avoidance of sleep. Treatment options are limited, and many patients cycle through medications without relief.
A newly reported case highlights a surprising potential role for ketamine for exploding head syndrome, offering hope for patients with severe and treatment resistant symptoms.
Understanding Exploding Head Syndrome
Exploding head syndrome is classified as a parasomnia, meaning it occurs during transitions between sleep and wakefulness. Patients often describe hearing thunder, gunshots, or electrical bursts that seem to originate inside the head. Visual flashes and brief paralysis may accompany the event. While the episodes are short and not dangerous, the emotional distress can be profound.
The exact cause remains unclear. Hypotheses include abnormal sensory gating, disrupted brainstem activity, or dysregulation of sleep related neural networks. Standard treatments include reassurance, sleep hygiene interventions, antidepressants, anticonvulsants, and anxiolytics. Unfortunately, many patients see little benefit.
A Refractory Case With Years Of Symptoms
The reported case involved a 75 year old man who had experienced exploding head syndrome for more than five years. His episodes occurred several times per week and included lightning like pain, loud thunderous sounds, flashes of light, sleep paralysis, and overwhelming fear. Despite extensive neurologic and psychiatric evaluations, no clear cause was identified.
The patient tried numerous medications, including nonsteroidal anti inflammatory drugs, migraine treatments, beta blockers, antidepressants, anticonvulsants, and anxiolytics. None meaningfully reduced the frequency of episodes. Brain imaging, EEG, and sleep studies were largely unremarkable, reinforcing the diagnosis of primary parasomnia rather than epilepsy or structural brain disease.
Ketamine For Exploding Head Syndrome
After nearly a decade of persistent symptoms, clinicians initiated sublingual ketamine at a low dose of 25 mg every third night, later increasing to nightly dosing. Ketamine is best known in psychiatry for its rapid antidepressant effects and its action on glutamate signaling through NMDA receptor antagonism.
Within one month, the patient reported a dramatic reduction in episode frequency. After three months, events occurred roughly once per month and were less intense. At six months, the exploding head sensations had fully resolved, with only occasional sleep paralysis remaining. The patient also reported improved sleep quality and reduced fear around bedtime.
Why Ketamine May Work
Although this is a single case, it raises intriguing mechanistic questions. Ketamine modulates glutamatergic transmission and may stabilize hyperexcitable neural circuits involved in sensory processing and sleep transitions. Exploding head syndrome may reflect transient cortical or brainstem disinhibition during sleep onset, a process ketamine could indirectly normalize.
Ketamine also has anxiolytic and dissociative properties that may reduce anticipatory fear and autonomic arousal, which often worsen parasomnia symptoms. These combined effects may explain the sustained improvement seen in this patient.
Clinical Implications And Caution
This case does not establish ketamine as a standard treatment for exploding head syndrome. Larger studies are needed, and clinicians should remain cautious when considering off label ketamine use. However, for patients with severe, refractory parasomnias, this report suggests that ketamine may warrant further investigation as part of interventional psychiatry research.
For researchers and clinicians, the case underscores how treatments developed for mood disorders may have broader applications across sleep and neuropsychiatric conditions.
Looking Ahead
Exploding head syndrome remains underrecognized and understudied. As interest grows in ketamine and other innovative modalities, carefully designed studies could clarify whether ketamine for exploding head syndrome represents a viable therapeutic pathway or an isolated response. For now, this case offers a compelling example of how novel interventions can emerge from interdisciplinary thinking.
Citations
- Sharpless BA. Exploding head syndrome. Sleep Medicine Reviews. 2014;18(6):489–493. https://doi.org/10.1016/j.smrv.2014.03.001
- Harutyunyan L, Liester M, Liang B. Successful Treatment of Exploding Head Syndrome With Ketamine. Cureus. 2025;17(11):e97558. doi:10.7759/cureus.97558. Full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC12724473/